bims-metlip Biomed News
on Methods and protocols in metabolomics and lipidomics
Issue of 2026–08–02
48 papers selected by
Sofia Costa, Matterworks



  1. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2026 Jul 20. 44(7): 594-598
      Objective: To establish a rapid method for the determination of doxepin and its metabolite nordoxepin residues in plasma samples by PRiME mixed cation-exchange solid-phase extraction coupled with ultra-performance liquid chromatography-high resolution mass spectrometry (PRiME MCX-UPLC-HRMS) . Methods: Plasma samples were extracted with 2% (V/V) aqueous phosphoric acid and purified by a PRiME MCX SPE cartridge. The target compounds were separated on an aurorasil MMP-G column (100 mm×2.1 mm, 3 μm) and gradient elution was performed with the mobile phases 5.0 mmol/L ammonium formate -0.1% (V/V) aqueous formic acid and methanol, and were determined in electrospray positive ionization mode (ESI(+)) and full mass scan-data dependent ms(2) scan (Full mass-ddMS(2)) mode, and the internal standard method was used for quantification. The limits of detection (LODs) and limits of quantification (LOQs) were calculated at signal-to-noise ratios of 3 and 10, respectively. Results: The linear ranges of doxepin and its metabolite nordoxepin were 1.0-100.0 ng/ml with correlation coefficients of 0.9988-0.9999. The LODs and LOQs for doxepin and its metabolite nordoxepin were determined to be 0.18-0.22 ng/ml and 0.54-0.66 ng/ml, respectively. The spiked recoveries of doxepin and its metabolite nordoxepin in plasma at the four concentration levels of 1.0 ng/ml, 10.0 ng/ml, 50.0 ng/ml and 80 ng/ml ranged from 90.8% to 105%, with relative standard deviations (RSDs) of 1.31%-4.59%. Conclusion: The method was rapid, sensitive and accurate and was suitable for the monitoring and analysis of doxepin and its metabolite nordoxepin in plasma samples from clinical patients.
    Keywords:  Chromatography, liquid; Doxepin; Nordoxepin; Plasma; SPE; Tandem mass spectrometry
    DOI:  https://doi.org/10.3760/cma.j.cn121094-20250402-00125
  2. Anal Chim Acta. 2026 10 01. pii: S0003-2670(26)00709-9. [Epub ahead of print]1417 345759
       BACKGROUND: Lipidomes are highly complex and variable, and high-throughput analytical strategies are essential for comprehensive lipidome profiling in large-scale analysis. The use of hydrophilic interaction liquid chromatography (HILIC) coupled with conventional untargeted acquisition strategies remains unpopular due to the challenges in interpreting complex spectral data. To address this gap, we present a detailed lipidomic workflow based on a fast 6.7 min-long HILIC separation method coupled with data-dependent acquisition/sequential window acquisition of all theoretical fragment ions analysis (DDA/SWATH) and improve its applicability with a novel framework for untargeted data processing. In parallel, we also established a targeted high-resolution multiple reaction monitoring (MRMHR) method for comprehensive multi-class lipidomic profiling. To evaluate the applicability of these two approaches in large-scale clinical lipidomics, we used both workflows for the analysis of 240 case-control matched plasma samples from a population-based prospective cohort.
    RESULTS: After method development and optimization, application of the two complementary workflows to 240 plasma samples generated lipid profiles of over 400 and 500 features for targeted and untargeted analysis, respectively. As expected, the coverage of lipids by the untargeted workflow was notably different from that of the targeted workflow at the lipid species level. In terms of quantitation of lipids detected in both approaches, we observed differences in the quantitation of lipids in individual samples, but statistical comparisons of sample groups remained largely concordant. Furthermore, we demonstrated that the choice of internal standards for normalization can influence downstream statistical outcomes.
    SIGNIFICANCE: Two fast HILIC-based workflows were demonstrated to be applicable for large-scale clinical lipidomics and represent reliable high-throughput alternatives to existing longer separation methods for both untargeted and targeted analyses using high-resolution mass spectrometry. Furthermore, the influence of targeted and untargeted approaches, together with the assessment of internal standard selection on downstream statistical outcomes, provides important methodological considerations for large-scale lipidomic studies.
    Keywords:  Data-dependent acquisition; Data-independent acquisition; High-resolution multiple reaction monitoring; Human plasma; Hydrophilic interaction liquid chromatography
    DOI:  https://doi.org/10.1016/j.aca.2026.345759
  3. Biomed Chromatogr. 2026 Sep;40(9): e70580
      The combination of avutometinib, a dual RAF/MEK inhibitor targeting the MAPK pathway, and defactinib, a selective focal adhesion kinase (FAK) inhibitor, represents a recently approved combination therapy for patients with KRAS-mutated or KRIS-mutated recurrent LGSOC (low-grade serous ovarian cancers). A comprehensive review of the literature indicates that although clinical studies have demonstrated the therapeutic potential of this combination, limited information is available regarding simultaneous quantification in biological matrices. Therefore, the present study mainly focused on a rapid selective and specific LC-MS/MS method that was developed and fully validated for the estimation of avutometinib and defactinib in rat plasma. Chromatographic separation was achieved using a reverse phase Kinetex PS C18 2.1*50 mm, 3.5 um, 100A° column under gradient elution with 0.1% formic acid in water and 0.1% formic acid in acetonitrile as mobile phases. The flow rate was 0.6 mL/min, and glyburide was employed as the internal standard (IS). Mass spectrometric detection was performed using positive electrospray ionization mode and multiple reaction monitoring was applied for the quantitative analysis. Protein precipitation with acetonitrile was used for sample preparation. The method demonstrated an excellent linearity range of 1 ng/mL to 1000 ng/mL for both analytes (r2 > 0.99). Intraday and interday accuracy and precision were observed to be within the acceptable regulatory limits for all quality control levels. Considering the limited availability of validated bioanalytical methods for this drug combination, the present work provides a robust and sensitive LC-MS/MS approach for the simultaneous quantification of avutometinib and defactinib. This validated method was successfully applied to a rat pharmacokinetic study following oral administration of both analytes.
    Keywords:  LC–MS/MS; LGSOC; avutometinib; defactinib; method validation; pharmacokinetics; rat plasma
    DOI:  https://doi.org/10.1002/bmc.70580
  4. Rapid Commun Mass Spectrom. 2026 Oct 30. 40(20): e70151
       RATIONALE: Chlorine gas is a highly toxic industrial chemical that poses a significant risk in accidental releases and deliberate terrorist attacks. Reliable analytical methods for the determination of chlorine in aqueous samples are therefore required for forensic and environmental investigations. This study aimed to develop a rapid and selective mass spectrometry-based method for chlorine determination following derivatization.
    METHODS: Chlorine in aqueous samples was derivatized with methyl 2-(3,4,5-trimethoxyphenyl)acetate (MTMPA) at 50°C for 15 min, yielding methyl 2-(2-chloro-3,4,5-trimethoxyphenyl)acetate (Cl-MTMPA). The derivatization product was analyzed by gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-tandem mass spectrometry (LC-MS/MS). While LC-MS/MS analysis was performed directly, GC-MS analysis required an additional liquid-liquid extraction step. Reaction conditions were optimized to maximize derivatization efficiency.
    RESULTS: The derivatization reaction provided a high yield of Cl-MTMPA under the optimized conditions. GC-MS and LC-MS/MS analyses produced a common major fragment ion at m/z 215.0. Further structural confirmation by liquid chromatography-high-resolution tandem mass spectrometry (LC-HRMS/MS) revealed a characteristic product ion at m/z 215.0473 generated from the precursor ion at m/z 275.0681. Calibration curves covering acute toxicologically relevant chlorine concentrations (5-200 mg/L) showed excellent linearity, with correlation coefficients (R2) exceeding 0.99.
    CONCLUSIONS: A rapid and selective derivatization-based method was developed in which the resulting chlorine derivative is readily analyzed by both GC-MS and LC-MS/MS. The method affords reliable analyte identification through characteristic fragmentation and excellent quantitative performance, making it suitable for forensic toxicology and environmental investigations involving chlorine exposure.
    Keywords:  GC–MS; LC–MS/MS; acute toxicity; aqueous samples; derivatization; free chlorine
    DOI:  https://doi.org/10.1002/rcm.70151
  5. Sci Rep. 2026 Jul 28. pii: 23496. [Epub ahead of print]16(1):
      A stepwise optimization guidance model for rapid multi-analyte UPLC-MS/MS is proposed to report recurring limitations in bioanalytical method development. The model involves six stages: (1) physicochemical profiling, (2) extraction strategy selection, (3) chromatographic optimization, (4) mobile phase selection, (5) method validation, and (6) greenness evaluation. The applicability of this framework was demonstrated by determining Rifaximin, Ciprofloxacin, and Fluconazole in spiked human plasma, using Ibuprofen as an internal standard. Physicochemical profiling guided the selection of ionization mode and prediction of solubility behavior. Based on the model recommendations, liquid-liquid extraction using dichloromethane was selected to achieve effective analyte recovery. Chromatographic optimization and mobile phase selection through the proposed framework supported the use of rapid isocratic separation on a C18 column using a methanol/water mixture (95:5, v/v) as mobile phase. The method validation, performed as an integral stage of the workflow according to regulatory guidelines, demonstrated exceptional linearity (r² ≥ 0.999). The final stage of the model involved evaluating environmental applicability using AGSA and EPPI analyses. The proposed sequential framework is intended to serve as a methodological reference for analysts employing LC-MS/MS platforms, to establish a structured and reproducible analytical workflow that advances ecological sustainability in multi-analyte LC-MS/MS bioanalytical applications.
    Keywords:  Ciprofloxacin; Fluconazole; Rifaximin; Stepwise optimization guidance model; UPLC–MS/MS
    DOI:  https://doi.org/10.1038/s41598-026-63587-9
  6. Metabolites. 2026 Jun 25. pii: 443. [Epub ahead of print]16(7):
      Background/Objectives: Mass spectrometry-based newborn screening for small-molecule biomarkers typically employs a rapid first-tier screen that omits chromatographic separations before mass spectrometric analysis, followed, only for a subset of samples and disorders, by a longer, more specific second-tier assay that includes liquid chromatographic separation prior to mass spectrometry. The second-tier screen is used when the primary biomarker lacks sufficient specificity and may result in higher false-positive rates. The throughput and specificity of first-tier newborn screening assays have been relatively stagnant over the past two decades despite significant improvements in mass spectrometry instrumentation. With the continuous expansion of disorders added to the Recommended Uniform Screening Panel in the United States, newborn screening laboratories have a need for higher-throughput assays and improved specificity. Methods: We developed and evaluated two first-tier tandem mass spectrometry approaches using a modern dual-needle, dual-loop LC-MS/MS platform: (1) a 30-s flow injection analysis tandem mass spectrometry (FIA-MS/MS) assay and (2) a rapid first-tier liquid chromatography tandem mass spectrometry (LC-MS/MS) assay using a hydrophilic interaction chromatography (HILIC) guard column (1TH). Analytical performance was assessed using dried blood spot quality control and linearity materials, including evaluations of recovery, precision, linearity, and matrix effects. Results: The 30-s FIA-MS/MS assay quadrupled the throughput of current 2-min FIA-MS/MS assays used routinely in newborn screening laboratories. The throughput improvement was achievable due to increased scan speeds of the mass spectrometer as well as the dual needle/loop design of the autosampler. In addition, these instrumentation improvements made it possible to employ liquid chromatographic separations prior to MS/MS analysis without sacrificing the approximately 2-min sample-to-sample throughput of conventional FIA-MS/MS workflows. The 1TH LC-MS/MS method separated critical isobaric and isomeric biomarkers, reduced matrix effects, improved specificity and quantification accuracy, and demonstrated acceptable recovery, precision, and linearity for newborn screening applications. Conclusions: Recent advances in LC-MS/MS instrumentation can be leveraged to either substantially increase first-tier newborn screening throughput or improve analytical specificity while maintaining current workflow timelines. First-tier LC-MS/MS using a HILIC guard column provides improved specificity that can reduce the need for second-tier testing, thereby improving overall throughput and turnaround time of the newborn screening workflow. These approaches provide flexible solutions for newborn screening laboratories seeking to accommodate expanding screening panels without compromising analytical quality or efficiency.
    Keywords:  acylcarnitines; amino acids; dried blood spots; high-throughput LC-MS/MS; newborn screening
    DOI:  https://doi.org/10.3390/metabo16070443
  7. Anal Chim Acta. 2026 10 01. pii: S0003-2670(26)00755-5. [Epub ahead of print]1417 345805
      Acidic phytohormones, such as abscisates, auxins, jasmonates, and salicylic acid, are low-abundance signalling molecules in plants. A high-throughput workflow coupling reverse phase based miniaturised solid phase extraction (RP-μSPE) with ultra-high performance supercritical fluid chromatography tandem mass spectrometry method (SFC-MS/MS) was established for their profiling, introducing complementary selectivity in sample clean-up and chromatographic separation. The SFC-MS/MS method was developed through stationary phase selection, design of experiment screening, and optimisation of chromatographic conditions, ion-source parameters, make-up solvent, injection volume, and gradient conditions. The Viridis HSS C18 SB column was selected among five stationary phases of different chemistries, supercritical CO2 and methanol as a co-solvent, containing 0.1% ammonia and 3% water, were employed as the mobile phase. Direct injection of 5 μL μSPE eluate enabled satisfactory peak shapes without an evaporation step. Methanol was used as the make-up solvent at 0.25 mL/min. The workflow was validated, providing accuracies within 85-115%, precision of 0.2-14.9%, matrix effects of 87-109%, limits of detection 2.5-250 fmol, linear ranges spanning 3-4 orders of magnitude, R2 0.9946-0.9999, and carry-over not exceeding 20%, for 19 acidic phytohormones passing the validation criteria. Compared to the routine RP-LC workflow, the SFC approach reduced chromatographic run time from 19 to 11 min, offered complementary selectivity, and decreased matrix effects. However, in SFC, the detection sensitivity was about one order reduced, two compounds were excluded from the method due to strong carry-over and one due to insufficient retention relative to LC. The workflow applicability was demonstrated by time-course profiling in wounded Arabidopsis thaliana leaves.
    Keywords:  Acidic phytohormones; High throughput; Mass spectrometry; Matrix effects; Supercritical fluid chromatography
    DOI:  https://doi.org/10.1016/j.aca.2026.345805
  8. Clin Chim Acta. 2026 Jul 25. pii: S0009-8981(26)00429-8. [Epub ahead of print]593 121247
      Arginine Vasopressin (AVP) is a nonapeptide synthesized in the hypothalamus and released by the neurohypophysis. It plays a central role in water and electrolyte homeostasis, urine concentration and blood pressure regulation. Dysregulation of AVP secretion is associated with several pathological conditions, including central diabetes insipidus and syndrome of inappropriate antidiuretic hormone secretion. Currently, AVP quantification mainly relies on immunoassays which suffers from limitations such as cross reactivity, limited sensitivity and complex sample handling. Given the very low endogenous concentrations of AVP in human plasma (low ng/L range), a highly sensitive LC-MS/MS method was developed and validated for plasma AVP quantification. AVP was extracted using Oasis WCX solid-phase extraction prior to LC-MS/MS analysis. PBS containing 0.1% BSA was used as surrogate matrix for calibration and validation samples to avoid endogenous interferences. Method validation was performed according to the Clinical Laboratory Standards Institute guidelines. Precision, accuracy, and measurement uncertainty were evaluated using single-nested analysis of variation and e.noval software. Stability in whole blood and plasma samples was also investigated. The method was validated over a concentration range from 0.2 ng/L to 60 ng/L, with precision (coefficient of variation) below 10%, accuracy ranging from 96% and 109%, measurement uncertainty below 15%, and a lower limit of quantification of 0.2 ng/L. EDTA blood samples remained stable up to 3 h at room temperature before centrifugation. In conclusion, we have developed and validated a highly sensitive LC-MS/MS method for the quantification of AVP in plasma. Our novel methodology is well-suited for clinical applications.
    Keywords:  Arginine-vasopressin; Liquid chromatography; Stability; Tandem mass spectrometry
    DOI:  https://doi.org/10.1016/j.cca.2026.121247
  9. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2026 Jul 20. 44(7): 589-594
      Objective: To establish a rapid and sensitive high performance liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) method for the simultaneous determination of 37 alkaloids in whole blood, in order to meet the needs of clinical alkaloid toxicity detection. Methods: From October 2024 to January 2025, whole blood samples were precipitated with acetonitrile and methanol (V∶V=1∶1) to remove proteins, followed by centrifugation, filtration and sample injection. A gradient elution was performed using a mobile phase containing 0.1% formic acid acetonitrile, 0.1% formic acid, and 5 mmol/L ammonium acetate aqueous solution. The injection volume was 1 μl at a flow rate of 0.4 ml/min. Separation was achieved on Waters XSelect(®)CSH(TM) C18 column. Mass spectrometry was operated in positive electrospray ionization with multiple reaction monitoring (MRM) mode, and quantification was performed using a matrix working curve external standard method. Results: The linear relationships between 37 alkaloids in whole blood were good within the corresponding concentration range, with correlation coefficients (r) all greater than 0.990. The detection limits (S/N) were 0.01-2.50 ng/ml, and the quantification limits were 0.03-7.50 ng/ml. The recovery rates were 81.1%-122.1%, and the intra and inter batch accuracies were 1.0%-13.9% and 2.3%-17.9%, respectively. Conclusion: This study establishes a rapid and sensitive LC-MS/MS for the simultaneous determination of 37 alkaloids in whole blood. The method is concise, rapid and sensitive, and can be used for the quantification of alkaloid poisoning toxins, monitoring of blood concentrations of medicinal alkaloids, and the detection of emergency response to sudden food poisoning incidents.
    Keywords:  Alkaloids; High performance liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS); Poisoning; Whole blood
    DOI:  https://doi.org/10.3760/cma.j.cn121094-20250217-00063
  10. J Am Soc Mass Spectrom. 2026 Jul 27.
      Targeted and untargeted mass spectrometric analyses of urine, a preferred matrix for toxicological screening, require comprehensive spectral libraries of drug metabolites. To detect new synthetic cannabinoids (SCs), biomarkers for newly emerging compounds must be incorporated rapidly. Unfortunately, reference standards for metabolites of new psychoactive substances (NPS) such as SCs are scarce. Since parent SCs are rarely detectable in urine, elucidating their metabolism poses a significant challenge for forensic toxicology laboratories. Untargeted high-resolution mass spectrometry (HRMS) approaches, often complemented by in silico methods, are increasingly vital to forensic toxicology and metabolomics. A pooled human liver microsome (pHLM) assay was used for in vitro generation of phase I metabolites of three prevalent SCs (ADB-BUTINACA, MDMB-BUTINACA, and MDMB-4en-PINACA). Analysis was performed by trapped ion mobility spectrometry-time-of-flight mass spectrometry (timsTOF-MS) using parallel accumulation serial fragmentation (PASEF) acquisition and MetaboScape software with the T-ReX (time-aligned region complete extraction) 4D workflow including in silico metabolite prediction, fragmentation, and collision cross section (CCS) forecasting. In addition, hydrolyzed and nonhydrolyzed SC-positive urine samples were reanalyzed with this workflow. Results showed successful annotation of predicted metabolites for all three SCs, including monohydroxylations and ester hydrolysis. Qualitative pHLM and urine findings were in good agreement. Compound-specific and most abundant in vivo metabolites were incorporated into a targeted UHPLC-QTOF-MS method to analyze 42 urine samples from the casework. Although complex multistep biotransformation reactions (e.g., ADB-BUTINACA dihydrodiol formation) continue to pose a challenge for in silico prediction, this approach is significantly less time-consuming and less labor-intensive than manual evaluation of known metabolic patterns.
    Keywords:  MetaboScape; T-ReX-4D annotation; collusion cross section (CCS); in silico metabolite prediction; new psychoactive substances; nontargeted workflow; synthetic cannabinoid receptor agonists; tims HRMS
    DOI:  https://doi.org/10.1021/jasms.6c00160
  11. Ann Pharm Fr. 2026 Jul 30. pii: S0003-4509(26)00115-X. [Epub ahead of print]
      A robust and highly sensitive LC-MS/MS method was developed and validated for the quantification of diosgenin in mice plasma in accordance with ICH M10 guidelines. Chromatographic separation was achieved using Kinetex C8 column (50 x 2.1 mm, 5 µm) with 0.1% formic acid in distilled water and methanol as mobile phase at a flow rate of 0.6 mL/min, and the run time was 17 min. Detection was performed in positive ESI+ mode using MRM at m/z 415.10 → 271.20, employing sarsasapogenin as the internal standard. Protein precipitation yielded efficient extraction with minimal matrix interference. The method exhibited excellent linearity over 3.125-1000 ng/mL (r2 = 0.996) with an LLOQ of 3.125 ng/mL. The accuracy during within-day and between-day evaluations ranged from 91.7% to 110.99%, and precision (%CV) remained below 5.14%. Dilution integrity indicated that the analyte can be reliably quantified in biological samples up to 24,000 ng/mL. The stability studies confirmed that the analyte was stable under various conditions. Further, this validated method was applied for pharmacokinetic studies in female mice via oral (10mg/kg) and intramuscular (5mg/kg) administration. Overall, the method is reliable for trace-level quantification and demonstrated its applicability in pharmacokinetic, bioavailability, and formulation studies of diosgenin.
    Keywords:  Bioanalytical validation; Chromatographic separation; Pharmacocinétique; Pharmacokinetics; Protein precipitation; Précipitation des protéines; Séparation chromatographique; Validation bioanalytique
    DOI:  https://doi.org/10.1016/j.pharma.2026.07.008
  12. Anal Bioanal Chem. 2026 Jul 28.
      Steroid hormones play crucial regulatory roles in human growth, development, reproduction, and the maintenance of internal environmental homeostasis. Because the concentrations of most hormones in the body are extremely low and their chemical properties vary widely, developing an accurate and sensitive quantitative method has become a primary objective in clinical diagnostics. In this study, an isotope dilution liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS) method was developed and validated for the simultaneous quantification of 22 steroid hormones in human serum. To enhance extraction and purification efficiency, a protein precipitation-solid-phase extraction (PP-SPE) approach was employed, forming a "dual purification" strategy. The limits of quantification for progesterone, cortisol, dihydrotestosterone, and dehydroepiandrosterone sulfate were 0.05, 0.50, 0.05, and 1.00 ng/mL, respectively, representing an improvement over previously reported values obtained using similar sample pretreatment methods. Method validation results demonstrated strong linearity for all 22 steroid hormones (R2 > 0.98). Accuracy ranged from 86.9% to 119.5%, intra-day precision was below 9.7%, inter-day precision was below 12.0%, and the matrix effect was controlled within 80.3%-118.1%. These findings indicate that the method is accurate, reliable, and suitable for analyzing multiple components in complex serum matrices. Twenty real serum samples were analyzed to evaluate the clinical applicability of the method. The results demonstrated that this method can be used clinically to monitor steroid hormone levels, assist in diagnosing and treating endocrine disorders, and provide a diagnostic basis for adrenal diseases. It holds significant reference value for clinical laboratory testing.
    Keywords:  LC-MS/MS; Protein precipitation; Serum; Solid-phase extraction; Steroid hormone
    DOI:  https://doi.org/10.1007/s00216-026-06587-y
  13. Biomed Chromatogr. 2026 Sep;40(9): e70575
      The identification of biomarkers and therapeutic targets is essential to the success of precision medicine. However, to reliably identify them, one must employ a combination of analytical and computational methods. This article describes the importance of high-quality study design, strict adherence to preanalytical and quality assurance practices and high levels of quality assurance as well as the performance characteristics of multiple types of chromatography/mass spectrometry to achieve the best possible results for sensitive, selective biomarker profiling in various biological fluids such as plasma, serum, urine, cerebrospinal fluid (CSF), and tissues. In addition, it explores the key workflows used in preparing biological samples (i.e., solid-phase extraction/specialised physical or chemical extractions/derivatisation), software/data processing pipelines for peak analysis (i.e., XCMS/MZmine/OpenMS/MS-DIAL) and processes for the identification of compounds by combining spectral libraries (e.g., Human Metabolome Database [HMDB], National Institute of Standards and Technology [NIST] and FiehnLib) with in silico tools (e.g., SIRIUS, CSI: FingerID, CANOPUS). Finally, it discusses several ways in which artificial intelligence/machine learning can be applied to the field of mass spectrometry for peak detection and provides a comprehensive review of the requirements for regulatory-grade validation and the workflow for targeted/multiplexed/quantitative liquid chromatography/mass spectrometry (LC/MS) and gas chromatography/mass spectrometry (GC-MS) using stable isotope-labelled internal standards.
    Keywords:  biomarker discovery; chromatography–mass spectrometry; computational workflows; data processing; regulatory‐grade method validation
    DOI:  https://doi.org/10.1002/bmc.70575
  14. Molecules. 2026 Jul 10. pii: 2420. [Epub ahead of print]31(14):
      Hair is an easily obtainable, non-invasive biomatrix that allows for the assessment of long-term physiological responses to environmental and anthropogenic stressors in wildlife populations. Herein, an ultra-high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry (UHPLC-ESI-MS/MS) method was validated to verify its suitability for the simultaneous determination of cortisol (CORT) and its metabolite, cortisone (CORN), in hair samples collected from wild-living grey wolves (Canis lupus). Hair samples were extracted with methanol and purified using solid-phase extraction on Strata-X cartridges, which enabled effective mitigation of matrix effects. Data for the glucocorticoids were normalized using internal standards. The method demonstrated good linearity for the target stress hormones, with satisfactory precision (RSD < 15%) and limits of quantification of 4.13 pg/mg for CORT and 2.49 pg/mg for CORN in the hair matrix. Analysis of authentic wolf hair samples revealed CORT and CORN concentrations in the ranges of <4.13-11.86 pg/mg and <2.49-3.67 pg/mg, respectively. The CORT results showed a strong positive correlation with those obtained using enzymatic immunoassays. The method may be applied to assess the impact of stressors on the welfare of wolves, e.g., providing a useful tool for monitoring recovering European populations as they face new challenges associated with expansion into potentially suboptimal habitats.
    Keywords:  Canis lupus; ELISA; conservation biology; glucocorticoids; method validation; steroid hormones; stress; wildlife
    DOI:  https://doi.org/10.3390/molecules31142420
  15. Pharmaceutics. 2026 Jun 24. pii: 770. [Epub ahead of print]18(7):
      Background/Objectives: Semaglutide, a long-acting glucagon-like peptide-1 (GLP-1) analog for type 2 diabetes and obesity, requires sensitive and high-throughput bioanalytical methods to support pharmacokinetic studies. However, previously reported liquid chromatography-tandem mass spectrometry (LC-MS/MS) assays have been limited by lengthy run times (~18 min) and suboptimal sensitivity. This study aimed to develop and validate a rapid, sensitive LC-MS/MS method for quantifying semaglutide in plasma. Methods: Plasma samples (50 μL) were prepared by acetone-mediated protein precipitation followed by solid-phase extraction. Chromatographic separation was performed on a Cadenza CD-C18 MF column within 9 min, using positive electrospray ionization in multiple reaction monitoring mode with the transitions m/z 1029.4 → 110.1 for semaglutide and m/z 938.9 → 109.9 for liraglutide (internal standard). Validation followed the U.S. Food and Drug Administration (FDA) bioanalytical guidelines. Results: The assay showed a lower limit of quantification of 1 ng/mL with linearity across 1-500 ng/mL (R2 = 0.9999), with sharp peak shape and no carryover. Intra- and inter-day accuracies were 95.69-103.76% and 94.93-100.08%, with precision ≤4.50% and ≤5.88%. Recovery (93.05-107.95%) and matrix effects (96.34-104.12%) were consistent across quality control levels, and the analyte was stable under all tested conditions. The method was successfully applied to a pharmacokinetic study in Sprague-Dawley rats following subcutaneous administration of 50 μg semaglutide. Conclusions: The validated method offers shorter analysis time, improved sensitivity, and reduced sample volume compared with previously reported assays, supporting its application in preclinical pharmacokinetic studies of semaglutide and related GLP-1 analogs.
    Keywords:  GLP-1; LC-MS/MS; semaglutide
    DOI:  https://doi.org/10.3390/pharmaceutics18070770
  16. J Pharm Biomed Anal. 2026 Jul 29. pii: S0731-7085(26)00354-7. [Epub ahead of print]281 117686
      Bortezomib is a proteasome inhibitor used to treat cancers such as Multiple Myeloma and Mantle Cell Lymphoma. Due to its narrow therapeutic index, accurate quantification in biological matrices is essential for monitoring drug exposure, optimizing dosing, and assessing tissue distribution. The aim of this study was to develop and validate LC-MS/MS methods for the quantification of bortezomib in rat serum and rat sciatic nervous tissue. A rapid serum assay based on one-step protein precipitation and a nervous tissue assay were established using 2H8-Bortezomib as an isotope labeled internal standard. Calibration ranges were 0.920-100 ng/mL for serum and 4.00-100 ng/g for nervous tissue. Bortezomib and its internal standard were detected using high-resolution MRM in positive-mode electrospray ionization, with a total acquisition time of 4 min per run. The serum method was validated according to ICH M10 guideline, ensuring compliance with parameters including accuracy, precision, matrix effects, recovery, stability, selectivity, reinjection reproducibility, and carry-over. The nervous tissue method underwent partial validation, assessing key parameters to ensure reliable quantification. The application of these methods to authentic rat samples demonstrated their suitability. The developed assays provide rapid and sensitive quantification of bortezomib in serum and sciatic nervous tissue. The simple sample preparation procedures and short run times support their use in pharmacokinetic and tissue distribution studies.
    Keywords:  Anticancer therapy; Bortezomib; LC-MS/MS; Sciatic nervous tissue; Serum concentration; Validation
    DOI:  https://doi.org/10.1016/j.jpba.2026.117686
  17. J Am Soc Mass Spectrom. 2026 Jul 26.
      Chemical derivatization has long been employed to enhance the structural characterization of lipids by mass spectrometry (MS). In recent years, olefin aziridination has emerged as a powerful and versatile strategy in lipidomics, driven by its ability to selectively target carbon-carbon double bonds (C═C bonds) and to introduce nitrogen-containing functionalities that facilitate both structural elucidation and quantitative analysis. Aziridination-enabled MS approaches provide reliable C═C bond localization through diagnostic fragmentation, while simultaneously improving ionization efficiency, particularly for nonpolar lipid classes. A diverse range of aziridination chemistry has been developed, each offering distinct advantages for lipid analysis. In this review, we summarize recent advances in aziridination-enabled MS methodologies, with an emphasis on reaction development and analytical performance. We further highlight applications across biological and complex sample systems. These developments highlight aziridination-assisted MS as a powerful strategy for precision lipidomics with isomer-resolved capability and accurate quantification.
    Keywords:  aziridination; lipidomics; mass spectrometry
    DOI:  https://doi.org/10.1021/jasms.6c00107
  18. J Am Soc Mass Spectrom. 2026 Jul 26.
      Elucidation of C═C unsaturation sites in biomolecules remains challenging using conventional tandem mass spectrometry techniques. Online ozonolysis inside a mass spectrometer offers a very specific C═C fragmentation strategy; however, adoption of the precursor-selective ozone-induced dissociation has been limited by its low reaction yields and the need for specialized mass spectrometers that can provide higher partial pressure of ozone and/or modifications to enable effective ion trapping. To make the online ozonolysis mass spectrometry more accessible, we present a setup in which ozone is introduced directly into the sheath gas line of a standard heated electrospray ionization source. This minimally modified online ozonolysis setup enables efficient interaction of ozone with electrospray droplets at atmospheric pressure while maintaining normal instrument operation and safety. In combination with reversed-phase liquid chromatography separation, this setup is very effective in annotating C═C positions in unsaturated biomolecules with just MS1 scanning by relying on the coelution of precursors and the ozonolysis product ions. This approach was validated across multiple lipid classes─including fatty acids, glycerophospholipids, sphingolipids, glycerolipids, and cholesteryl esters─as well as selected natural products, in complex mixtures and under both positive and negative ion modes. Reaction yields varied among analytes yet remained sufficient for unambiguous C═C position assignment. This LC-OzESI-MS strategy provides an efficient and easily adoptable platform for high-throughput structural characterization of unsaturated biomolecules, even in complex sample matrices.
    DOI:  https://doi.org/10.1021/jasms.6c00205
  19. Anal Chim Acta. 2026 Oct 01. pii: S0003-2670(26)00785-3. [Epub ahead of print]1417 345835
       BACKGROUND: Identification of known natural products (NPs) in complex plant extracts is essential for plant metabolomics, natural product dereplication and discovery of bioactive components from medicinal herbs.
    RESULTS: We propose FSIWsim, a Fragment Size- and Intensity- Weighted MS2 similarity algorithm for NP identification in complex extracts based on LC-MS/MS data. FSIWsim computes and ranks MS2 spectral cosine similarity between query and reference spectra from a curated MS2 spectral database containing 677,356 compounds. The similarity is evaluated in a combined feature space encompassing all matched fragment ions and neutral losses, and unmatched fragment ions, with weighting by both fragment size and intensity. On the CASMI 2017 dataset, FSIWsim achieved a top-1 identification accuracy of 45.96%. Validation of FSIWsim using 43 certified natural product standards achieved a top-5 accuracy of 90.70%. Application of FSIWsim to Euphorbia helioscopia L. extract (EHL) enabled identification of 101 known NPs, including 20 confirmed using authentic standards. For those that were not correctly identified, candidates structurally similar to an identified analogue-despite having a different precursor m/z-could be retrieved from a broader chemical structure database via substructure or structure similarity searches, enabling plausible annotation of the query spectrum.
    SIGNIFICANCE: FSIWsim provides a robust measure of structural similarity and serves as an effective alternative tool for identifying known NPs in complex plant extracts, while also enabling the annotation of compounds absent from the spectral database but structurally similar to identified analogues.
    Keywords:  Combined feature space; Fragment size- and intensity- weighted; MS(2) similarity; Natural product identification; Structural analogue
    DOI:  https://doi.org/10.1016/j.aca.2026.345835
  20. Brief Bioinform. 2026 Jul 03. pii: bbag378. [Epub ahead of print]27(4):
      Confidently identifying lipids in samples is a prerequisite for understanding their many functions in health and disease. However, accurate molecular lipid species identification via tandem mass spectrometry remains challenging. Most current approaches match measured spectra against an in-house reference library, which hinders the comparability of results. To address this challenge, the transformer model LipiDetective was developed and trained on a dataset of spectra from lipid standards, databases, and publications. Learning the characteristic lipid fragmentation patterns, LipiDetective can accurately annotate molecular lipid species in tandem mass spectra independently of the experimental setup. Integrated gradients reveals that LipiDetective focuses on peaks matching known fragments, making its predictions humanly interpretable. Therefore, LipiDetective offers a data-driven approach for molecular lipid species identification that may improve the comparability of annotations across different laboratories and analysis workflows.
    Keywords:  deep learning; lipid identification; lipidomics; mass spectrometry; transformer neural network
    DOI:  https://doi.org/10.1093/bib/bbag378
  21. PLoS Comput Biol. 2026 Jul 29. 22(7): e1014586
       BACKGROUND: Clustering analysis is a foundational step in exploratory data analysis workflows, with dimensionality reduction methods commonly used to visualize multidimensional data in lower-dimensional spaces and infer sample clustering. Principal Component Analysis (PCA) is widely applied in metabolomics but is often suboptimal for clustering visualization. Metabolomics data often require specialized manipulations such as blank removal, quality control adjustments, and data transformations that demand efficient visualization tools. However, the lack of user-friendly tools for clustering without computational expertise presents a challenge for metabolomics researchers. ClusterApp addresses this gap as a web application that performs Principal Coordinate Analysis (PCoA), expanding clustering alternatives in metabolomics. Built on a QIIME 2 Docker image, it enables PCoA computation and Emperor plot visualization. The app supports data input from GNPS, GNPS2, or user-provided spreadsheets. Freely available, ClusterApp can be locally installed as a Docker image or integrated into Jupyter notebooks, offering accessibility and flexibility to diverse users.
    RESULTS: To demonstrate the data preprocessing techniques available in ClusterApp, we analyzed two Liquid Chromatography coupled to Tandem Mass Spectrometry (LC-MS/MS) metabolomics datasets: one exploring metabolomic differences in mouse tissue samples and another investigating coral life history stages. Among the dissimilarity measures available, the Bray-Curtis measure effectively highlighted key metabolomic variations and patterns across both datasets. Targeted filtering significantly enhanced data reliability by retaining biologically relevant features, 10,617 in the coral dataset and 7,341 in the mouse dataset while eliminating noise. The combination of Total Ion Current (TIC) normalization and auto-scaling improved clustering resolution, revealing distinct separations in tissue types and life stages. ClusterApp's flexible features, such as customizable blank removal and group selection, provided tailored analyses, enhancing visualization and interpretation of metabolomic profiles.
    CONCLUSION: ClusterApp addresses the need for accessible, dynamic tools for exploratory data analysis in metabolomics. By coupling data transformation capabilities with PCoA on multiple dissimilarity matrices, it provides a versatile solution for clustering analysis. Its web interface and Docker-based deployment offer flexibility, accommodating a wide range of use cases through graphical or programmatic interactions. ClusterApp empowers researchers to uncover meaningful patterns and relationships in metabolomics data without requiring cumbersome data manipulation or advanced bioinformatics expertise.
    DOI:  https://doi.org/10.1371/journal.pcbi.1014586
  22. Biomed Chromatogr. 2026 Sep;40(9): e70583
      Thiopurine immunosuppressive drugs are indicated in children with acute lymphoblastic leukemia and in both children and adults with chronic inflammatory diseases. Therapeutic drug monitoring (TDM) of its DNA-incorporated metabolites 6-thioguanine nucleotides (6TGN) and 6-methylmercaptopurine nucleotides (6MMPN) is of high interest to optimize efficacy and prevent toxicity. The objective of this study was to develop and validate a sensitive and simple LC-MS/MS method for the simultaneous quantification of 6TGN and 6MMPN in whole blood for TDM. Following red blood cell count and whole blood extraction with dithiothreitol plus acidic hydrolysis at 100°C, quantification was performed using an LC-MS/MS in positive ionization mode. Calibration curves were linear over the range of 20-1000 ng/mL for 6TGN and 20-20,000 ng/mL for 6MMPN, with correlation coefficients above 0.99 for all analytes. Intra- and inter-day precisions were below 9.45%. Extraction recovery and matrix effects reached 78.9%-83.2% and 121% for 6TGN and 92.2%-95.2% and 112%-118% for 6MMPN, respectively. The method was applied to 749 clinical samples from patients with acute lymphoblastic leukemia or chronic inflammatory diseases. A sensitive and simple LC-MS/MS method was validated for 6TGN and 6MMPN in whole blood and was successfully applied to clinical samples for TDM.
    Keywords:  6MMPN; 6TGN; therapeutic drug monitoring; thiopurine; whole blood
    DOI:  https://doi.org/10.1002/bmc.70583
  23. Anal Bioanal Chem. 2026 Jul 30.
      Consumption of food containing residues of nitrofuran metabolites may pose potential risks to human health. Although many countries have prohibited the use of nitrofurans as veterinary drugs, their illegal application persists. The detection of nitrofuran (NF) metabolites is essential for ensuring food safety. In this study, we designed and synthesized a pair of novel isotope-coded derivatization (ICD) reagents, 2-(4-formylphenyl)-1-phenyl-1H-naphtho[1,2-d]imidazole (d0-PPIB) and 2-(4-formylphenyl)-1-(pentadeuteriophenyl)-1H-naphtho[1,2-d]imidazole (d5-PPIB), using phenyl as the isotope-coded group. With the aid of the ICD reagents, a sensitive and accurate method for determination of NFs using ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) was established. The instrumental analysis time is remarkably short, with the four target analytes separated within just 4 min. The derivatization process was efficiently completed in only 15 min using microwave-assisted techniques, substantially reducing the overall experimental duration. The method achieved excellent sensitivity, with detection limits ranging from 0.011 to 0.019 μg/L, and the measurement error ranged from -2.2 to 3.5%. The intra- and inter-day precision was consistently high, with relative standard deviations (RSDs) below 5%. This ICD-based strategy effectively mitigates matrix effects while reducing costs and improving accuracy. Using one pair of ICD reagents (d0/d5-PPIB), multiple analytes are concurrently derivatized to generate their isotope-labeled internal standards, markedly decreasing commercial stable isotope-labeled (SIL) internal standard consumption. The method was successfully applied to quantify NF metabolites in three food samples.
    Keywords:  Isotope-coded derivatization; Nitrofuran metabolites; UHPLC-MS/MS
    DOI:  https://doi.org/10.1007/s00216-026-06703-y
  24. Anal Chim Acta. 2026 10 01. pii: S0003-2670(26)00759-2. [Epub ahead of print]1417 345809
       BACKGROUND: Reliable quantification of amyloid-β (Aβ) peptides in biological fluids is of major clinical and research interest in Alzheimer disease context. Conventional offline extraction approaches often involve labor-intensive manual steps and high solvent consumption, limiting throughput routine applications, reproducibility, and sustainability. To address these limitations, this study reports the development of an online coupling between a monolithic oligosorbent (mOS) in capillary and high-performance liquid chromatography-mass spectrometry (HPLC-MS) method for selective Aβ peptide analysis.
    RESULTS: A mOS was incorporated online in a set up including a C18 trap column coupled with an HPLC-MS analytical system. Systematic optimization of mOS loading/elution conditions, trapping column desalting/preconcentration, and chromatographic mobile phase composition enabled efficient retention, transfer, and separation of Aβ40 and Aβ42 in a fully automated method. This method achieved lower limits of quantification down to 0.03 ng mL-1 with good precision and accuracy (CV ranging from 1.1 to 6.2% for Aβ40 and from 4.3 to 10.9% for Aβ42). Comparative evaluation of offline and online extraction using the same mOS capillary demonstrated improved reproducibility and enhanced sensitivity for the online configuration. The method's applicability to a controlled CSF-like matrix was demonstrated using artificial cerebrospinal fluid (aCSF) diluted 1:2 (v/v) in binding buffer (BB), yielding recoveries of 60% for Aβ40 and 34% for Aβ42.
    SIGNIFICANCE: The online coupling of the mOS capillary with HPLC-MS also represents a strategic advance toward environmentally responsible bioanalysis. Indeed, the superior AGREEprep score (0.7) for the online configuration compared to offline mode (0.59), underscores its alignment with green analytical chemistry principles, reflecting reductions in solvent use, manual intervention, and overall environmental burden.
    Keywords:  Amyloid-β peptide; Aptamer; Capillary extraction; Miniaturized sample preparation; Monolithic oligosorbent
    DOI:  https://doi.org/10.1016/j.aca.2026.345809
  25. Biomed Chromatogr. 2026 Sep;40(9): e70571
      Cloxacillin (CLX) and oxacillin (OXA), two isoxazolyl β-lactam antibiotics widely used against penicillinase-producing Staphylococcus aureus, have attracted increasing attention due to their environmental persistence, residue occurrence, and analytical complexity across diverse matrices. This review provides a critical and integrated comparison of analytical techniques for the determination of CLX and OXA in pharmaceutical, biological, food, and environmental samples, addressing key challenges, including β-lactam instability, low intrinsic detectability, strong protein binding, and matrix interferences. Chromatographic methods, particularly HPLC and LC-MS/MS, remain the most reliable approaches, offering high selectivity and stability-indicating capability, with LC-MS/MS achieving superior sensitivity at ng/mL levels suitable for trace analysis, albeit at higher cost and with greater operational demands. Electrochemical techniques, especially nanomaterial- and molecularly imprinted-based sensors, demonstrate promising sensitivity and rapid response, though limitations in reproducibility and standardization persist. In contrast, spectroscopic methods are economical and simple but restricted by low sensitivity and poor selectivity in complex matrices. Overall, no single technique is universally optimal, and analytical performance is strongly matrix-dependent. Future perspectives should prioritize the development of hybrid, standardized, and green analytical platforms that balance sensitivity, robustness, and cost-effectiveness, alongside harmonized validation strategies to enable reliable and sustainable monitoring of CLX and OXA in real-world applications.
    Keywords:  chromatography; cloxacillin and oxacillin; electrochemical analysis; isoxazolyl β‐lactam; spectroscopy
    DOI:  https://doi.org/10.1002/bmc.70571
  26. J Mass Spectrom. 2026 Aug;61(8): e70093
    MDR‐TB MUKT and RePORT India Team, Indo‐South Africa Study Team and PREEMPT Study Teams
      Multidrug-resistant tuberculosis (MDR-TB) remains a major cause of morbidity and mortality worldwide, with people living with HIV experiencing persistently poor treatment outcomes. Clofazimine and bedaquiline are cornerstone drugs in contemporary all-oral MDR-TB regimens, yet their complex pharmacokinetics and substantial interindividual variability complicate regimen optimisation, particularly in vulnerable populations. Robust plasma-based drug quantification is essential to characterise exposure-response relationships and inform individualised therapy. We developed and validated a rapid, sensitive and specific liquid chromatography-tandem mass spectrometry assay for quantifying these drugs in human plasma. The methods were successfully applied on plasma samples from study participants with MDR-TB with or without HIV coinfection who received clofazimine and bedaquiline as part of MDR-TB therapy assessing the Cmax, Tmax and AUC in both groups. The method addresses key analytical challenges posed by clofazimine's extreme lipophilicity and reliably quantifies concentrations across a broad, clinically relevant range, including potentially toxic exposures. Linearity was obtained between 0.0313 to 4.0 mg/L, and the method met bioanalytical method validation criteria along with interlab comparison with a reference laboratory, all within acceptable limits. We observed significantly lower Cmax concentrations of both drugs among HIV-infected participants compared to HIV-uninfected participants (p = 0.011 for clofazimine and p = 0.02 for bedaquiline), highlighting the need for therapeutic drug monitoring in this vulnerable group. This work provides a robust analytical foundation for pharmacokinetic, therapeutic drug monitoring and exposure-response studies of key MDR-TB drugs and supports efforts to optimise treatment outcomes, especially among people living with HIV.
    Keywords:  India; LC–MS/MS; bedaquiline; clofazimine; multidrug‐resistant tuberculosis
    DOI:  https://doi.org/10.1002/jms.70093
  27. Drug Des Devel Ther. 2026 ;20 622839
       Background: Mycophenolic acid (MPA), administered as mycophenolate mofetil (MMF) or enteric-coated mycophenolate sodium (EC-MPS), is the first-line immunosuppressant for kidney transplant patients. Traditional plasma-based therapeutic drug monitoring (TDM) for MPA fails to accurately reflect intracellular drug exposure at the pharmacological action site.
    Purpose: This study aimed to establish and validate a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for simultaneous quantification of MPA and its glucuronide metabolite, MPAG, in peripheral blood mononuclear cells (PBMCs) to support cellular pharmacokinetic (PK) assessment.
    Methods: Chromatographic separation was performed on a BEH C18 column using methanol-water containing 0.1% formic acid and 5 mmol/L ammonium acetate. A total of 139 PBMC samples from 40 kidney transplant recipients (n=19 receiving EC-MPS; n=21 receiving MMF) were analyzed to evaluate the plasma-PBMC PK correlations and gender-related differences.
    Results: The method exhibited excellent linearity over the concentration range of 0.2-500 ng/mL (R2 > 0.998), along with acceptable precision, accuracy and matrix effect. The analytes remained stable under various experimental conditions. Significant inter-individual variability in intracellular MPA and MPAG concentrations was observed among patients. Spearman correlation analysis demonstrated a weak-to-moderate positive correlation between plasma and intracellular PBMC concentrations of MPA (EC-MPS, Rs=0.396; MMF, Rs=0.480). Additionally, the concentration-time profiles of MPA and MPAG in PBMCs of kidney transplant recipients after administration of EC-MPS or MMF exhibited different characteristics. No significant gender-based differences in plasma and PBMCs were observed.
    Conclusion: We established and validated an LC-MS/MS method for simultaneous quantification of intracellular MPA and MPAG. The observed weak-to-moderate correlation between plasma and PBMC exposure highlights the inherent limitations of conventional plasma-based TDM for MPA. Collectively, our study provides a feasible approach for monitoring intracellular drug levels and facilitates the optimization of individualized immunosuppressive dosing regimens for renal transplant recipients.
    Keywords:  LC-MS/MS; enteric-coated mycophenolate sodium; mycophenolate mofetil; mycophenolic acid; mycophenolic acid glucuronide; therapeutic drug monitoring
    DOI:  https://doi.org/10.2147/DDDT.S622839
  28. Biomed Chromatogr. 2026 Sep;40(9): e70578
      For many years, it is known as Nitrosamines are responsible for carcinogenicity in human. These nitroso-impurities were found detected in plastics, food items, cigarette, insect killer, water and alcoholic beverages. In 2018 EMA and USFDA claimed the presence of N-nitrosodimethylamine in valsartan used for the treatment of hypertension. Consequently, to assess the adverse effects of nitrosamine generation during storage, in the course of production, or through contaminated supply chains, regulators have issued many guidelines. Hence, there is a crucial need for accurate evaluation technique to measure nitroso-impurities in pharmaceutical products. According to the Carcinogenic Potency Categorization Approach, the allowable intake is 400 ng/day, which translates to an allowable limit of 16 ppm for a 25 mg daily dose. A study was then performed at 1.5 ppm relative to sample concentration, which is less than 10% of this limit. The main aim of this development to optimize and prove suitability of a new liquid chromatography-tandem mass spectrometry method for quantitatively analyzing 3-amino-N-nitrosopiperidine (NTPA) in Alogliptin Benzoate (AGP), achieving detectable response of 0.03 ppm and quantifiable response value of 0.1 ppm relative to sample concentration. Current method was found to be linear with the coefficient of regression of 0.9979. Also, spiking study was performed by the calculating percentage spiked NTPA in the drug, which ranged from 96.67% to 100.14%. The results confirmed that the methodology was reliable, precise, robust and reproducible to quantify NTPA at 1.5 ppm in samples of 2.75 mg/mL concentration.
    Keywords:  3‐amino‐N‐nitrosopiperidine (NTPA); Alogliptin benzoate (AGP); liquid chromatography tandem mass spectrometry; nitrosamine; validation
    DOI:  https://doi.org/10.1002/bmc.70578
  29. Mol Cell Proteomics. 2026 Jul 31. pii: S1535-9476(26)00128-3. [Epub ahead of print] 101632
      Peptides secreted by pancreatic islet cells regulate glucose homeostasis. and their dysregulation may contribute to metabolic disorders such as diabetes and pancreatic disease. We use nanospray desorption electrospray ionization mass spectrometry imaging (nano-DESI MSI) to identify and map intact and truncated C-peptides in mouse pancreatic tissue. Alongside commonly observed lipids and metabolites, we detected 36 multiply charged acidic peptides that preferentially ionize in negative mode. On-tissue tandem mass spectrometry (MS/MS) was used to identify them as intact C-peptide isoforms and multiple truncated variants, including several not previously reported peptides. Molecular networking of MS/MS data assigned some unidentified species to C-peptide families based on shared fragmentation patterns. Ion images revealed distinct distributions of truncated peptides, with chemical gradients extending from β-cells into peri-insular acinar cells, suggesting their potential roles in endocrine-exocrine communication. These findings demonstrate the power of nano-DESI MSI for identifying and spatial mapping of novel peptides, which is critical for understanding their roles in pancreatic tissues.
    Keywords:  Immunofluorescence (IF) Imaging; Islets of Langerhans; Mass Spectrometry Imaging (MSI); Molecular Networking; Nanospray Desorption Electrospray Ionization (nano-DESI); Peptides
    DOI:  https://doi.org/10.1016/j.mcpro.2026.101632
  30. Glycobiology. 2026 Jul 28. pii: cwag057. [Epub ahead of print]
      Glycosylation is a fundamental post-translational and lipid modification that plays critical roles in diverse cellular processes. Although mass spectrometry (MS) is the primary platform for glycomic analysis, large-scale interpretation of glycomic MS data remains heavily dependent on expert manual annotation, creating a major bottleneck. Key challenges include effective spectral denoising and reliable identification of glycan-derived tandem MS (MS2) spectra. Here, we present GlycoMsHelper, a simple and flexible R-based workflow for positive-ion mode glycomic MS composition analysis. GlycoMsHelper integrates multiple denoising strategies with logical expression-based recognition of diagnostic fragment ion patterns to identify glycan-derived MS2 spectra. Candidate spectra are matched against glycan libraries constructed using curated biosynthetic constraints, generating traceable outputs for downstream validation. By defining appropriate parameters, the workflow can be applied to diverse glycan classes, including N-glycans, O-glycans, and glycosphingolipids (GSLs). Because each module operates independently, produces standardized outputs, and is supported by a graphical user interface, GlycoMsHelper can be readily integrated into existing glycomic analysis workflows. In an N-glycan MS dataset containing 43 expert-curated compositions, GlycoMsHelper correctly identified 42 compositions. Application to GSL and O-glycan datasets further demonstrated its versatility and enabled identification of glycan compositions overlooked during manual annotation. GlycoMsHelper is particularly useful for exploratory analysis of newly acquired or previously uncharacterized datasets lacking established reference libraries, providing an accessible and practical solution for semi-automated composition-level interpretation of glycomic MS data.
    Keywords:  Glycan annotation; Glycoinformatics; Glycomics; Mass spectrum; Spectral denoising
    DOI:  https://doi.org/10.1093/glycob/cwag057
  31. Anal Bioanal Chem. 2026 Jul 25.
      The analysis of paper-based food contact materials (FCM) has gained increasing attention due to the widespread use of per- and polyfluoroalkyl substances (PFAS) and their known toxic effects and environmental persistence. As regulatory frameworks for PFAS in FCM remain limited, sensitive and reliable analytical methods are necessary to ensure food safety. While PFAS analysis is predominantly performed using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS), a systematic development of gas chromatography coupled to mass spectrometry (GC-MS)-based methods for multiple PFAS classes remains limited. In this study, two pre-column derivatization techniques were optimized and evaluated for GC-MS determination of perfluoroalkyl carboxylic acids (PFCA), fluorotelomer alcohols (FTOH), and fluorotelomer carboxylic acids (FTCA). Both derivatization methods enabled qualification and quantification of the targeted PFAS with comparable limits of detection in the low ng/mL range. N,N-Dimethylformamide dimethyl acetal (DMFDMA) derivatization proved to be more sensitive with a limit of detection down to 0.85 ng/mL. In addition, this derivatization approach was successfully automated within the GC-MS workflow, resulting in sample preparation times comparable to those of LC-MS-based methods. The application of this optimized method to paper-based FCM demonstrated its suitability for real world FCM analysis. Results of PFAS content per targeted PFAS of 26.6 to 261.4 ng/g highlight the potential of GC-MS analysis, particularly when combined with automated derivatization, as a viable alternative or complement to LC-MS for PFAS analysis in FCM.
    Keywords:  Automatization; Derivatization; FCM; Gas chromatography-mass spectrometry; PFAS
    DOI:  https://doi.org/10.1007/s00216-026-06683-z
  32. Anal Chim Acta. 2026 10 01. pii: S0003-2670(26)00760-9. [Epub ahead of print]1417 345810
       BACKGROUND: In the last decades, algae have emerged as highly promising candidates for revolutionizing food systems, being an important source of omega-3 fatty acids. Given the high complexity and diversity of lipids in macroalgae, researchers have been challenged to develop suitable analytical methodologies for the complete characterization of all lipids and isolation of omega-3 species to be used as human dietary supplements.
    RESULTS: In this research, an "omic" approach was developed to exhaustively elucidate lipids in different species of commercial and infesting marine macroalgae by exploiting hyphenated chromatography-mass spectrometry techniques and ambient sampling/ionization mass spectrometry. In detail, gas chromatography coupled to mass spectrometry and flame ionization detection was employed for the determination of fatty acids ethyl esters, while reversed-phase liquid chromatography-tandem mass spectrometry afforded both class-type separation and lipid assignment within the native lipids. Particular emphasis was placed on miniaturization and full automation of the sample preparation procedures using robotic platforms online coupled to chromatographic instrumentations. In parallel, a rapid evaporative ionization mass spectrometry system equipped with an electrosurgical knife was also used as shotgun technique to obtain macroalgae lipid fingerprinting. Finally, supercritical fluid chromatography was employed to isolate fatty acid ethyl esters, aiming to produce omega-3 enriched formulations.
    SIGNIFICANCE: Macroalgae appear to be sustainable alternative sources of omega-3 fatty acids pursuing the objectives of the Sustainable Blue Economy and the Bio-Based Circular Economy. Significantly, the present research enhanced the valorization of marine macroalgae in the nutraceutical context, supporting their use as an effective non-animal source of essential fatty acids.
    Keywords:  Ambient mass spectrometry; Automated sample preparation; Miniaturization and automation; Nutraceuticals; Omega-3 isolation; Supercritical fluid chromatography
    DOI:  https://doi.org/10.1016/j.aca.2026.345810
  33. Chem Biodivers. 2026 Jul;23(7): e71508
      The rhizomes of white galangal (Alpinia galanga) and red galangal (Alpinia purpurata) are valued as herbal medicines and pesticides. However, these two plants may exhibit differing bioactivities and side effects due to variations in their metabolite compositions. Differentiating the rhizomes of the two plants in dried, chopped, or powdered form can be challenging, raising concerns about misidentification and fraud. This study aimed to distinguish between the two rhizomes using a pseudo-targeted metabolomics approach integrated with multivariate analysis and MS/MS spectra-based molecular networking. Metabolites were extracted via ultrasonic treatment in methanol, followed by untargeted LC-MS Q-Orbitrap and pseudo-targeted LC-MS triple quadrupole analyses. Principal component analysis (PCA) effectively separated the two rhizomes and highlighted metabolite features contributing to this separation. Hierarchical cluster analysis (HCA) clustered samples by plant type and location, and also showed differences in metabolite distribution patterns. Molecular networking, interpreted in conjunction with PCA loading scores, revealed distinct molecular cluster patterns. Finally, the study confirmed that differences in metabolite composition and molecular patterns enable accurate differentiation. This approach offers a reliable method for authenticating rhizomes, ensuring herbal quality control, and preventing counterfeiting.
    Keywords:  LC‐MS/MS; clustering analysis; galangal rhizomes; metabolite fingerprinting; pseudo‐targeted metabolomics
    DOI:  https://doi.org/10.1002/cbdv.71508
  34. Anal Chim Acta. 2026 10 01. pii: S0003-2670(26)00745-2. [Epub ahead of print]1417 345795
      Salvianolic acid derivatives (SADs) represent a cluster of hydrosoluble phenolic acids and typically exist as monomer and oligomer forms in Salviae miltiorrhizae Radix et Rhizoma (Chinese name: Danshen). Because of the high-level structural similarity, even isomerism, it is technically challenging to achieve satisfactory separation and confidence-enhanced identification using conventional LC-MS/MS approaches. Here, an integrated strategy was proposed through simultaneously advancing LC separation, MS/MS information acquisition, and post-acquisition data processing. LC×LC was configured using HSS T3 and 5C18-AR-II columns for 1st and 2nd-dimensional separations, respectively, attributing to their sufficient complementary capabilities. By applying several data acquisition modes on the hybrid triple quadrupole-linear ion trap (QTRAP)-MS platform, including precursor ion scan, neutral loss scan, predictive multiple reaction monitoring, and step-wise multiple ion monitoring, a total of 143 SADs were captured. To facilitate structural identification, high-resolution mass values of all concerned SADs were obtained by LC-QTOF-MS. Meanwhile, a bottom-up structural annotation workflow was constructed by applying a tandem energy-resolved MS program. For signals-of-interest, the substructures were identified by matching full exciting energy ramp (FEER)-MS3 spectra with FEER-MSn (n = 2 or 3) spectra of known structures or fragments, and the linkage patterns amongst substructures were deciphered by incorporating full collision energy ramp (FCER)-MS2 spectra with quantum chemical calculation. As a result, confidence-enhanced structure identification was reached for 11 monomers, 19 dimers, 59 trimers, and 54 tetramers. Together, the strategy integrating LC×LC, diverse MS/MS modes, and bottom-up structural annotation enabled in-depth SADs-focused characterization in Danshen, providing a promising tool for chemical characterization of herbal medicines.
    Keywords:  Full collision energy ramp-MS(2) spectrum; Full exciting energy ramp-MS(n) spectrum; LC×LC; Salviae miltiorrhizae Radix et Rhizoma; Salvianolic acid derivatives; Tandem energy-resolved mass spectrometry
    DOI:  https://doi.org/10.1016/j.aca.2026.345795
  35. Life (Basel). 2026 Jul 16. pii: 1177. [Epub ahead of print]16(7):
      Spatial multi-omics analyzes biomolecules such as the proteome, metabolome, and lipidome within their native spatial context in tissues or cells. Mass spectrometry imaging (MSI) has emerged as a powerful technique for mapping the region-specific molecular distribution in regions of interest (ROIs). Laser capture microdissection coupled with mass spectrometry (LCM-MS) is another well-established workflow, enabling the accurate characterization of biomolecules in ROIs. To advance the current analytical application, we expanded a matrix-assisted laser desorption/ionization (MALDI)-MSI-guided LCM-MS workflow for integrated multi-omics analysis and applied it to mouse brain tissue as a proof-of-principle validation. MALDI-MSI annotated 387 putative metabolites and lipids, revealing distinct molecular distributions between the cortex and hippocampus. Both regions were subsequently isolated as ROIs using LCM and analyzed by LC-MS/MS metabolomics, lipidomics, and proteomics to achieve accurate biomolecular profiling. LC-MS/MS metabolomics and lipidomics annotated 249 compounds, several of which exhibited distinct abundance patterns between the two regions. LC-MS/MS proteomics matched to over 3500 protein groups across the two regions. Biological network analysis revealed strong associations between molecular pathways and known region-specific phenotypes. Overall, this MALDI-MSI-guided LCM-MS workflow enables comprehensive spatial multi-omics profiling and quantitative biomolecular analysis, providing valuable insights into complex biological systems and spatial molecular organization.
    Keywords:  LC-MS/MS; laser capture microdissection; mass spectrometry imaging; matrix-assisted laser desorption/ionization; spatial multi-omics
    DOI:  https://doi.org/10.3390/life16071177
  36. bioRxiv. 2026 Jul 21. pii: 2026.07.17.739095. [Epub ahead of print]
      RNA modification analysis by LC-MS/MS is central to epitranscriptomics, yet quantitative comparison across laboratories and instrument platforms remains poorly standardized. Here, we performed a community-driven benchmarking study during the first Human RNome Project workshop to systematically evaluate cross-platform reproducibility of ribonucleoside mass spectrometry workflows. Using the same analytical column and gradient, standardized RNA samples, and shared reagents, we compared nucleoside quantification across quadrupole, time-of-flight, and orbitrap-based LC-MS platforms employing distinct acquisition strategies. While chromatographic separation was highly reproducible across systems, nucleoside-specific MS response behavior differed substantially between platforms and limited direct comparability of relative signal intensities. These response differences varied across analytes and concentration ranges, demonstrating that harmonized chromatography alone is insufficient for transferable quantitative analysis. Stable isotope-labeled internal standard (SILIS) normalization substantially reduced platform-and method-dependent response and improved agreement for most evaluated modifications. External calibration improved agreement between qTOF and Orbitrap workflows for a subset of modifications but did not fully resolve residual intersystem differences. Based on these findings, we establish benchmark-derived recommendations for harmonized relative and absolute RNA modification quantification, including guidance for calibration design, quality control, and data reporting. Together, this work provides a methodological framework for reproducible nucleoside LC-MS/MS workflows and establishes a foundation for large-scale comparative epitranscriptomic studies.
    Graphical abstract:
    DOI:  https://doi.org/10.64898/2026.07.17.739095
  37. Vaccines (Basel). 2026 Jun 30. pii: 581. [Epub ahead of print]14(7):
      Background: The m7G cap structure, which mimics the natural cap of eukaryotic mRNA, is a critical determinant of mRNA vaccine efficacy, safety, and stability. However, its precise quantification remains challenging due to complex impurity profiles and the high physicochemical similarity between the target cap and related impurities. Although liquid chromatography mass spectrometry (LC-MS) is widely employed for this purpose, current methodologies still face significant limitations, including labor-intensive sample preparation, low analytical throughput, poor reproducibility in quantifying low-level impurities, and a lack of universally applicable strategies across diverse mRNA vaccine platforms. Methods: We systematically optimized sample preparation and LC-MS detection workflows. RNase H-mediated cleavage was compared with DNAzymes, guide DNA probes were rationally designed, and thermostable RNase H was introduced for one-step denaturation and cleavage. To establish an accurate, efficient, and universal sample preparation workflow. Chromatographic conditions were optimized using an ion-pairing reagent system to suppress ESI-MS metal adducts. Eliminating sample purification improves recovery, reduces manual handling errors, and boosts assay efficiency. Results: Through optimally designed guide DNA probes, RNase H cleavage specificity reached ≥98% with high cleavage efficiency, offering higher efficiency than DNAzyme. Furthermore, the incorporation of thermostable RNase H enabled a single-step workflow combining high-temperature denaturation and site-specific cleavage, substantially streamlining sample preparation. On the chromatographic side, optimization of the ion-pairing reagent system effectively suppressed metal adduct formation in electrospray ionization mass spectrometry (ESI-MS). This advancement enabled direct injection of the 5' cap fragments without purification, achieving high-recovery quantification while demonstrating broad compatibility across mainstream LC-MS platforms. The optimized assay reduces the total analytical workflow from 4~6 h to under 1.5 h. Conclusions: Combining high accuracy, robustness, and broad platform compatibility, this method offers a universal, high-throughput analytical solution for mRNA vaccine quality control and continuous process development.
    Keywords:  LC-MS; capping efficiency; mRNA vaccine; quality control
    DOI:  https://doi.org/10.3390/vaccines14070581
  38. Ther Drug Monit. 2026 Jul 31.
       BACKGROUND: Venetoclax is a B-cell lymphoma 2 inhibitor with breakthrough therapy designations and is used in the treatment of acute myeloid leukemia, particularly in patients ineligible for conventional cytotoxic chemotherapy. However, these drugs exhibit extensive pharmacokinetic variability among patients. Therapeutic drug monitoring (TDM) is useful in determining venetoclax dosage regimens. This study aimed to develop a high-throughput method for the quantification of plasma venetoclax concentration using ultrahigh-performance liquid chromatography coupled with tandem mass spectrometry (UHPLC-MS/MS) and to apply this method to TDM.
    METHODS: After a simple solid-phase extraction step using a 96-well µElution plate, venetoclax was analyzed using UHPLC-MS/MS in positive electrospray ionization mode. This novel method fulfilled the requirements of the US Food and Drug Administration guidelines for bioanalytical assay validation, with a 4 ng/mL lower limit of quantification. The calibration curves were linear over a concentration range of 4-50,000 ng/mL.
    RESULTS: The recovery rate was 96.2 ± 18.0% (mean ± SD). The imprecision was below 7.2% coefficient of variation, and the accuracy was within 10.4% for all quality control levels. The matrix effect varied from 80.6% to 97.9%. This assay was successfully applied to the TDM of trough concentrations in 3 patients treated with venetoclax for acute myeloid leukemia.
    CONCLUSIONS: We successfully developed a novel high-throughput UHPLC-MS/MS method for quantifying venetoclax in human plasma. This method can be applied for TDM in patients receiving venetoclax in clinical settings.
    Keywords:  acute myeloid leukemia; high-throughput; pharmacokinetics; plasma venetoclax concentration; therapeutic drug monitoring; ultrahigh-performance liquid chromatography coupled to tandem mass spectrometry
    DOI:  https://doi.org/10.1097/FTD.0000000000001514
  39. J Chromatogr A. 2026 Jul 23. pii: S0021-9673(26)00621-7. [Epub ahead of print]1785 467293
      Radioactive effluents, in particular sludges, are particularly challenging samples to analyse. Before their management in dedicated disposals facilities, quantification of chelating agents potentially present in these matrices, such as EDTA (ethylenediaminetetraacetic acid), is required. In a recent study, a unified protocol was established and validated for the accurate measurement of five chelating agents (NTA/ nitrilotriacetic acid, EDTA, DTPA/diethylenetriaminepentaacetic acid, TTHA/triethylenetetraminehexaacetic acid and gluconic acid) in sludges. This study provides detailed insights into the behaviour of these chelating agents during the overall HPLC-ESI-HRMS analysis process. Based on speciation calculations, some complexes are supposed to be doubly-charged species after sample pretreatment but during LC-MS experiments, due to the ionization process in mass spectrometry, only singly-charged species were detected. This gave a new highlight on the mechanisms involved in HPLC separation and ESI source and showed that attention has to be paid to the analytes speciation when performing LC-MS experiments. Moreover, it permitted to better understand the origin of the heavy chromatographic matrix effects caused by the sample, and counter them by an optimal dilution or the addition of ammonium acetate in the mobile phase. Lastly, a particular behaviour was observed for DTPA complex, transforming from a Ni2-DTPA form to a Ni-DTPA one during HPLC separation. A thorough understanding was achieved towards separation mechanisms, matrix effects and speciation changes. This knowledge is crucial for further development on new molecules or types of samples.
    Keywords:  Aminopolycarboxylic acid; EDTA; Gluconate; HPLC-ESI-MS; Nuclear waste; Speciation
    DOI:  https://doi.org/10.1016/j.chroma.2026.467293
  40. J Pharm Biomed Anal. 2026 Jul 22. pii: S0731-7085(26)00333-X. [Epub ahead of print]281 117665
      The increasing demand for Cannabis-derived medicinal products in Brazil, coupled with the implementation of RDC 1013/2026 (ANVISA), necessitates robust analytical frameworks for pharmacological and forensic purposes. This study is part of the "Paracelsus Project," a feasibility study evaluating the production of plant-based active pharmaceutical ingredients (API) from seized Cannabis sativa L. (marijuana), aiming to repurpose material that is currently incinerated. Preliminary data suggests this seized material contained a total of roughly 25 tons of CBD. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated for the simultaneous determination of twelve phytocannabinoids (CBD, D9-THC, D8-THC, CBC, CBL, CBN, CBG, THCV, CBDV, CBDVA, CBGA, and THCA). The methodology utilized a triple quadrupole (QQQ) analyzer in positive ionization mode, designed to overcome the challenges of complex plant matrices and chemical isomers. The method achieved successful baseline separation of critical pairs, such as CBD/CBG and D9-THC/D8-THC, in under eight minutes. This analytical workflow was successfully applied to monitor cannabinoid concentrations during the extraction and purification processes from seized marijuana by Brazilian Federal Police. The validated LC-MS/MS method provides the necessary sensitivity and specificity for both quality control in API production and forensic standardization. By establishing a technical foundation for characterizing medicinal extracts and ensuring compliance with the 0.3% THC statutory threshold, this research supports public health safety and the potential for a sustainable pharmaceutical supply chain from seized materials in Brazil.
    Keywords:  LC-MS/MS; Method validation; Phytocannabinoids; Seized Cannabis
    DOI:  https://doi.org/10.1016/j.jpba.2026.117665
  41. J Chromatogr A. 2026 Jul 13. pii: S0021-9673(26)00597-2. [Epub ahead of print]1785 467269
      Bile acids (BAs) are recognized as established disease biomarkers, yet quantitative studies have largely focused on serum or plasma, with insufficient attention paid to intestinal contents that hold significant pathophysiological importance. Accurate quantification of intestinal BAs is key to elucidating disease mechanisms. However, this analysis remains highly challenging due to the complex matrix of intestinal contents and the presence of numerous bile acid isomers. This study focuses on developing and validating a rapid, accurate, and sensitive UPLC-MS/MS method for the simultaneous quantification of 42 BAs (covering 11 isomer groups) in intestinal contents, and its application to depression research. Samples were pretreated using lyophilization followed by composite solvent extraction. Chromatographic separation used a CORTECSTM Premier T3 column with gradient elution. Among the 11 isomer groups, baseline separation was achieved for most of them. The method validation results showed excellent linearity with r2 ≥ 0.996; recoveries ranged 86.73% - 111.03%; stability tests under various conditions including room temperature storage for 24 h, 4 °C for 7 days, -80 °C for 90 days, and three freeze-thaw cycles yielded RSD ≤ 14.41%. Intra-day and inter-day precision RSD ≤ 16.10%. The lower limits of quantification ranged from 0.1 to 2.0 ng/mL. Applying to intestinal contents from a CUMS-induced depression SD rat model, the method revealed significant differences in 14 BAs compared with normal rats, among which Iso-HDCA was upregulated as much as 6-fold, suggesting that BAs detection should be given attention in exploring the mechanisms of depression.
    Keywords:  Bile acids; Depression; Isomer-specific separation; Method validation; UPLC-MS/MS
    DOI:  https://doi.org/10.1016/j.chroma.2026.467269
  42. Drug Test Anal. 2026 Jul 28.
      Nitazenes are highly potent synthetic opioids of increasing concern in clinical and forensic toxicology, thus underscoring the need for sensitive and selective analytical methods for biological specimens. This study describes the development and validation of an LC-MS/MS method for the quantification of nitazene analogs and related metabolites in plasma using micro-QuEChERS sample preparation. The validated concentration range was 0.05-20 ng/mL, with coefficients of determination R2 > 0.99. The limit of detection (LOD) was 0.025 ng/mL, and the lower limit of quantification (LLOQ) was 0.05 ng/mL. Bias ranged from -2.6% to 15.7%, within-run precision from 3.4% to 12.7%, and between-run precision from 4.4% to 14.9%, as evaluated at three quality control levels. Matrix effects and recovery were analyte-dependent but compatible with satisfactory overall validation performance. No interferences or carryover were observed. Method applicability was demonstrated in an authentic intoxication case, in which N-pyrrolidino protonitazene was quantified at 1.4 ng/mL, representing, to our knowledge, the first clinical case reported in Brazil. The case was clinically characterized by severe opioid toxicity requiring repeated naloxone administration. The proposed method combined low sample volume, simple sample preparation, and suitable analytical performance for targeted analysis of emerging nitazene compounds. These findings support the use of micro-QuEChERS and LC-MS/MS as a practical approach for targeted nitazene quantification in clinical and forensic toxicology.
    Keywords:  LC–MS/MS; micro‐QuEChERS; nitazenes; plasma; toxicology
    DOI:  https://doi.org/10.1002/dta.70126
  43. Anal Chim Acta. 2026 10 01. pii: S0003-2670(26)00762-2. [Epub ahead of print]1417 345812
      RNA modifications are vital for all living organisms. A total of at least 63 types of uridine modification have been discovered, accounting for the largest proportion of all reported RNA modifications. Uridine modifications have also been shown to be dysregulated in various human diseases. However, it's well known that mass spectrometry analysis of uridine modifications is limited by their low ionization efficiencies. Here, we developed a simple and robust method for the simultaneous identification and quantification of 22 uridine modifications in biological samples. In fact, uridine and lots of its modifications are more easily ionized in negative ion mode, compared with positive ion mode commonly used. Besides, the fragmentation patterns of uridine modifications in negative ion mode could provide more structural information, compared with well-known glycosidic bond cleavage in positive ion mode. Furthermore, simply by adding 0.2 mM acetic acid into the mobile phase, the peak areas of uridine and all 22 uridine modifications in negative ion mode could be improved by 4.1-55.4 folds. With this novel method, we quantified 16, 14, 10, 12 and 16 uridine modifications in 293T total RNA, 293T small RNA, E. coli tRNA, S. cerevisiae tRNA and wheat germ tRNA, accordingly. This study provides a general good method for researchers interested in the identification and quantification of uridine modifications in various biological samples.
    Keywords:  Mass spectrometry; Modified ribonucleosides; Negative ion mode; RNA modification; Uridine modification
    DOI:  https://doi.org/10.1016/j.aca.2026.345812
  44. J Chromatogr B Analyt Technol Biomed Life Sci. 2026 Jul 24. pii: S1570-0232(26)00312-0. [Epub ahead of print]1282 125223
      Bile acids (BAs) facilitate the digestion and absorption of fats and influence lipid and glucose homeostasis, making them potential therapeutic targets for obesity and related metabolic disorders. The liver and intestinal microbiota modify BAs structurally, generating diverse chemical forms and isomers. Comprehensive profiling of the BA pool is critical for understanding their key biological functions and as a therapeutic approach for related diseases. High-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) is usually chosen as the preferred method for BA detection due to the complex chemical structures, the wide range of actual concentrations and the complexity of fecal sample matrices. However, free BAs are difficult to ionize, resulting in low detection signals and a lack of characteristic structural fragments to assist in structural identification. In this method, the labeling reagent (2-aminoethyl) trimethylammonium (AETMA) is employed to label the carboxyl group of BAs. Compared with underivatized BAs, the detection sensitivity of unconjugated BAs was enhanced by 25-180 fold, while that of conjugated BAs increased by 6-160 fold. It also generates unique fragment ions and enhances MS response, facilitating the discovery of potential BAs. Methodological parameters were validated using 38 BAs as representatives. Through methodological validation, it was verified that the precision, recovery, matrix effect and stability parameters of the method met acceptable criteria. We also identified 61 confirmed BAs and 55 additional candidate BAs in human pooled fecal samples. It has been successfully applied to fecal BA analysis in obese populations, providing valuable insights into potential therapeutic strategies for obesity.
    Keywords:  Bile acid; Derivatization; Fecal; LC-MS/MS
    DOI:  https://doi.org/10.1016/j.jchromb.2026.125223
  45. J Chromatogr A. 2026 Jul 27. pii: S0021-9673(26)00624-2. [Epub ahead of print]1785 467296
      Anti-doping and forensic science detection rely fundamentally on target-based methodologies, especially for metabolite screening and identification. Traditional manual screening is constrained by low efficiency and knowledge bias. Conversely, although current metabolomics and machine-learning approaches efficiently calculate lots of potential biomarkers using statistical methods, these findings necessitate further rigorous screening to isolate true biomarkers that satisfy the requirements of both anti-doping and forensic science. To bridge the gap between machine learning and manual screening, we developed an innovative reverse-metabolomics strategy: utilizing LCHRMS for Phase II conjugate automated prediction as well as GCHRMS for targeted Phase I tentative validation. In the study of 6β‑chloro-testosterone (6β-Cl-T) metabolism, while LCHRMS (via Compound Discoverer software) initially predicted 244 putative phase II metabolites, the integration of GCHRMS, following the release of Phase I metabolites and subsequent derivatization, acted as a high-precision filter to further elucidate these candidates. 74 of the 244 candidates were putatively validated as candidate biomarkers. Eliminating high-throughput false positives, this workflow boosts data confidence in anti-doping and clinical metabolomics.
    Keywords:  6β‑chloro-testosterone; Compound discovery; LC-HRMS. GC-HRMS; Metabolomics
    DOI:  https://doi.org/10.1016/j.chroma.2026.467296
  46. Anal Chim Acta. 2026 Oct 01. pii: S0003-2670(26)00763-4. [Epub ahead of print]1417 345813
       BACKGROUND: Ambient Ionization Mass Spectrometry (AIMS) enables rapid, high-throughput chemical analysis with minimal sample preparation, but produces complex, information-rich spectra that require robust preprocessing and multivariate analysis. Numerous normalization, scaling, and transformation strategies are routinely applied, yet their selection is often empirical and poorly justified. Using edible oil authentication and type-determination as a model system, this work systematically evaluates ten preprocessing strategies combined with multiple dimensionality reduction and classification methods. The problem addressed is the lack of a quantitative, evidence-based framework for selecting optimal preprocessing and analysis workflows for AIMS data.
    RESULTS: Ten preprocessing approaches were quantitatively assessed in combination with Principal Component Analysis (PCA), sparse PCA (sPCA), and Partial Least Squares Discriminant Analysis (PLS-DA), followed by Naïve Bayes, Support Vector Machines (SVM), and Linear Discriminant Analysis (LDA) classifiers. Performance was evaluated using explained variance, clustering index, projected chromatographic resolution (Rs), and classification accuracy. No universally optimal workflow was identified; instead, performance depended strongly on data characteristics. Log2 transformation consistently outperformed alternative preprocessing methods, yielding superior cluster separation and classification accuracy for this dataset. PCA and PLS-DA performed comparably and outperformed sPCA, while LDA achieved the highest classification accuracy. In contrast, commonly used Total Ion Count (TIC) normalization degraded performance and, in some cases, produced misleading classifications. Two visualization tools are introduced: an importance spectrum highlighting discriminative m/z features, and a synthetic chromatographic projection enabling intuitive interpretation of multivariate separability. Although demonstrated using LMJ-SSP AIMS data, the framework is broadly applicable to conventional MS workflows.
    SIGNIFICANCE: This study provides the first comprehensive, quantitative framework for optimizing preprocessing, dimensionality reduction, and classification for AIMS data analysis. By demonstrating that commonly used methods can underperform or mislead, it shifts workflow selection from convention to evidence. The proposed metrics and visualization tools improve interpretability, rigor, and reproducibility, enabling more reliable classification and feature discovery in mass spectrometry-based research.
    Keywords:  Ambient Ionization Mass Spectrometry (AIMS); Classification model; Liquid microjunction; Mass spectrometry data analysis; Multivariate analysis; Partial Least-Squares Discriminant Analysis (PLS-DA); Principal Component Analysis (PCA); Sparse PCA (sPCA); Surface sampling probe (LMJ-SSP)
    DOI:  https://doi.org/10.1016/j.aca.2026.345813
  47. J Pharm Biomed Anal. 2026 Jul 22. pii: S0731-7085(26)00337-7. [Epub ahead of print]281 117669
      Phosphatidylethanol (PEth) is currently considered the most specific direct biomarker of alcohol consumption in blood, with a detection window of up to four weeks. Its clinical and occupational applications have expanded considerably, leading to increasing demand for reliable PEth determination. Although Dried Blood Spot (DBS) sampling provides clear logistical and pre-analytical advantages, sample preparation remains labor-intensive and prone to variability. This study describes the development and validation of a semi-automated LC-MS/MS method for PEth quantification using DBS, designed for high-throughput routine use. The analytical workflow combines automated DBS identification and punching in 96-well extraction plate and LC-MS/MS analysis with automatic and secured data transfer to the Laboratory Information Management (LIM) system. Method validation was conducted in accordance with EMA and ISO 15189 requirements and then applied to authentic venous patient DBS. The calibration curve covered a concentration range from 10 to 1000 µg/L with accuracy and precision of + /-15% for all levels. The low limit of quantification (LLOQ) was 10 µg/L and the upper limit of quantification linearity (ULOQ) was 1000 µg/L while the quantification range was extended up to 2500 µg/L, maintaining acceptable accuracy and precision. Analytical run time was 9 min, with no detectable interferences, carry-over or matrix effect, demonstrating high selectivity. Among 346 patient samples analyzed, 67 exceeded the 200 µg/L threshold defined by the Basel consensus to be classified as chronic alcohol consumers. This validated semi-automated DBS LC-MS/MS method provides a robust, sensitive, and high-throughput approach for rapid routine PEth determination, enhancing analytical standardization, reliability, and traceability in clinical and forensic laboratories.
    Keywords:  Alcohol consumption; Dried Blood Spots (DBS); LC-MS/MS; Phosphatidylethanol (PEth); Semi-automated method
    DOI:  https://doi.org/10.1016/j.jpba.2026.117669
  48. Anal Chim Acta. 2026 10 01. pii: S0003-2670(26)00722-1. [Epub ahead of print]1417 345772
       BACKGROUND: Fructans (FOS) and raffinose family oligosaccharides (RFOs) are two major water-soluble carbohydrates in higher plants. Despite the development of diverse analytical methods, determining the complete FOS and RFOs structures remains challenging. A workflow that can be directly applied for comprehensive structural determination of FOS and RFOs was developed in this study.
    RESULTS: The first step of the workflow follows a conventional strategy: HPLC retention times and MS2 spectra of unknown oligosaccharide are compared to those of standards in a database. Structures that can be determined in this step are limited to the available standards. For oligosaccharides that do not match database entries, the second step is applied. Individual isomers are subjected to acid and/or enzyme hydrolysis to generate disaccharides and smaller oligosaccharides. Structures of these disaccharides/small oligosaccharides are determined by comparing HPLC retention times and MS2 spectra with database. Complete oligosaccharide structure is reconstructed from these identified disaccharides/small oligosaccharides using logically derived sequence tandem mass spectrometry (LODES/MSn). In the third step, new disaccharides and small oligosaccharides generated by acid/enzyme hydrolysis and the new oligosaccharides which structures are determined in the second part are added into database. The new data benefits the next oligosaccharide structural determination.
    SIGNIFICANCE AND NOVELTY: As this workflow is repeatedly applied to find new oligosaccharides, the database may eventually cover most natural FOS and RFOs. We first applied workflow to FOS extracted from onion and identified a previously unreported tetrasaccharide in onion, then applied to other species, demonstrating the capability for rapid isomeric identification of FOS and RFOs.
    Keywords:  Fructan; LODES/MS(n); Mass spectrometry; Raffinose family oligosaccharide; Structure
    DOI:  https://doi.org/10.1016/j.aca.2026.345772